Suppr超能文献

用13-顺式维甲酸口服治疗重症痤疮。临床结果(作者译)

[Oral treatment of severe forms of acne with 13-cis-retinoic acid. Clinical results (author's transl)].

作者信息

Plewig G, Wagner A, Braun-Falco O

出版信息

MMW Munch Med Wochenschr. 1980 Sep 19;122(38):1287-93.

PMID:6450893
Abstract

A new, very effective method of treating severe forms of acne (papuplopustular, conglobate, fulminating and tetrad) is the oral administration of 13-cis-retinoic acid. The results described by Peck et al. (1979) in 14 patients are demonstrated in detail in 18 patients. In the initial therapy 1 to 2 mg/kg body weight were administered daily for 12 weeks without any other local or systemic treatment. In the second phase of the study half the patients continued treatment with 0.5 mg/kg body weight 13-cis-retinoic acid, the other half remaining without any further therapy. All inflammatory lesions healed after 12-16 weeks, sebum production was largely reduced. 13-cis-retinoic acid represents a remarkable turn in the treatment of most severe acne.

摘要

一种治疗重度痤疮(丘疹脓疱型、聚合性、暴发性和四型痤疮)的全新且非常有效的方法是口服13 - 顺式维甲酸。佩克等人(1979年)在14名患者身上所描述的结果在18名患者身上得到了详细验证。在初始治疗阶段,每天给予1至2毫克/千克体重的剂量,持续12周,不进行任何其他局部或全身治疗。在研究的第二阶段,一半患者继续使用0.5毫克/千克体重的13 - 顺式维甲酸进行治疗,另一半则不再接受任何进一步治疗。所有炎症性皮损在12 - 16周后愈合,皮脂分泌大幅减少。13 - 顺式维甲酸代表了重度痤疮治疗方面的重大转变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验